See more : China Sanjiang Fine Chemicals Company Limited (CNSJF) Income Statement Analysis – Financial Results
Complete financial analysis of LifeTech Scientific Corporation (1302.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LifeTech Scientific Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- Jaguar Mining Inc. (JAG.TO) Income Statement Analysis – Financial Results
- G Squared Ascend II Inc. (GSQB) Income Statement Analysis – Financial Results
- Doha Insurance Group Q.P.S.C. (DOHI.QA) Income Statement Analysis – Financial Results
- KCC GLASS Corporation (344820.KS) Income Statement Analysis – Financial Results
- Wendell Industrial Co., Ltd (6761.TWO) Income Statement Analysis – Financial Results
LifeTech Scientific Corporation (1302.HK)
About LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; manufacturing and trading of materials for hemp; staff training and internal personnel management business; information consulting for investors; and manufacturing and trading of medical devices, as well as technical, consulting, and technology services. It has operations in Mainland China, India, rest of Asia, Europe, South America, Africa, and internationally. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.27B | 1.10B | 925.33M | 642.30M | 668.88M | 556.70M | 409.13M | 352.85M | 311.61M | 282.68M | 231.04M | 181.48M | 140.32M | 104.70M |
| Cost of Revenue | 271.54M | 223.38M | 177.80M | 129.15M | 134.06M | 101.68M | 77.17M | 76.32M | 59.03M | 52.54M | 42.40M | 36.18M | 27.36M | 21.07M |
| Gross Profit | 995.64M | 873.93M | 747.53M | 513.15M | 534.82M | 455.02M | 331.96M | 276.53M | 252.58M | 230.14M | 188.64M | 145.30M | 112.97M | 83.64M |
| Gross Profit Ratio | 78.57% | 79.64% | 80.79% | 79.89% | 79.96% | 81.74% | 81.14% | 78.37% | 81.06% | 81.41% | 81.65% | 80.07% | 80.50% | 79.88% |
| Research & Development | 297.92M | 208.48M | 145.89M | 167.27M | 141.11M | 115.20M | 62.20M | 57.53M | 47.22M | 33.31M | 31.04M | 23.61M | 22.76M | 15.44M |
| General & Administrative | 149.25M | 102.48M | 97.02M | 104.11M | 132.40M | 95.35M | 52.95M | 51.62M | 47.57M | 75.67M | 63.22M | 37.90M | 44.88M | 16.95M |
| Selling & Marketing | 265.34M | 245.22M | 194.15M | 216.37M | 166.47M | 129.63M | 84.77M | 81.57M | 73.60M | 69.08M | 52.12M | 41.22M | 34.55M | 20.06M |
| SG&A | 414.59M | 347.70M | 291.18M | 320.48M | 298.86M | 224.98M | 137.72M | 133.20M | 121.17M | 144.75M | 115.34M | 79.12M | 79.43M | 37.01M |
| Other Expenses | -100.15M | -25.23M | -16.20M | -15.69M | -27.11M | 35.25M | 10.55M | 1.26M | 1.29M | 1.03M | 1.20M | 1.22M | -5.02M | -3.33M |
| Operating Expenses | 612.36M | 530.95M | 420.86M | 472.06M | 412.86M | 337.43M | 144.89M | 175.84M | 159.69M | 173.52M | 141.19M | 96.34M | 97.18M | 49.12M |
| Cost & Expenses | 883.90M | 754.33M | 598.66M | 601.21M | 546.92M | 439.11M | 222.06M | 252.16M | 218.72M | 226.06M | 183.59M | 132.52M | 124.53M | 70.19M |
| Interest Income | 12.78M | 16.65M | 7.67M | 6.65M | 2.34M | 3.28M | 2.75M | 1.72M | 1.83M | 2.69M | 4.04M | 2.35M | 0.00 | 0.00 |
| Interest Expense | 722.00K | 632.00K | 2.61M | 25.69M | 20.22M | 282.00K | 812.00K | 16.04M | 13.25M | 11.25M | 10.15M | 7.78M | 0.00 | 23.96M |
| Depreciation & Amortization | 77.16M | 67.11M | 62.05M | 62.63M | 55.19M | 32.56M | 17.02M | 10.21M | 7.77M | 7.31M | 6.96M | 7.32M | 6.39M | 4.70M |
| EBITDA | 253.46M | 445.78M | 397.59M | 133.30M | 246.22M | 200.03M | 211.45M | 120.10M | 82.34M | 59.19M | 48.53M | 56.28M | 22.18M | 39.22M |
| EBITDA Ratio | 20.00% | 45.30% | 47.57% | 20.75% | 34.00% | 36.67% | 51.64% | 34.04% | 26.42% | 20.94% | 21.01% | 31.01% | 15.81% | 37.46% |
| Operating Income | 383.28M | 368.43M | 328.74M | 70.67M | 188.76M | 164.19M | 192.21M | 108.31M | 94.45M | 49.78M | 42.21M | 48.96M | 15.79M | 34.52M |
| Operating Income Ratio | 30.25% | 33.58% | 35.53% | 11.00% | 28.22% | 29.49% | 46.98% | 30.69% | 30.31% | 17.61% | 18.27% | 26.98% | 11.25% | 32.97% |
| Total Other Income/Expenses | -207.70M | 2.11M | 4.19M | -21.87M | -17.94M | 3.00M | 1.42M | 78.65M | -68.06M | -117.60M | -95.40M | -7.27M | 3.29M | -24.11M |
| Income Before Tax | 175.58M | 378.05M | 332.93M | 242.62M | 170.81M | 167.19M | 193.62M | 186.95M | 26.40M | -67.81M | -53.19M | 41.68M | 19.08M | 10.41M |
| Income Before Tax Ratio | 13.86% | 34.45% | 35.98% | 37.77% | 25.54% | 30.03% | 47.33% | 52.98% | 8.47% | -23.99% | -23.02% | 22.97% | 13.60% | 9.94% |
| Income Tax Expense | 68.09M | 59.31M | 49.57M | 35.58M | 43.65M | 45.84M | 30.05M | 41.24M | 22.37M | 12.92M | 12.19M | 8.82M | 6.52M | 6.62M |
| Net Income | 263.24M | 325.34M | 292.47M | 216.09M | 129.20M | 121.08M | 163.47M | 145.65M | 2.36M | -81.24M | -65.67M | 32.35M | 11.83M | 3.94M |
| Net Income Ratio | 20.77% | 29.65% | 31.61% | 33.64% | 19.32% | 21.75% | 39.96% | 41.28% | 0.76% | -28.74% | -28.42% | 17.83% | 8.43% | 3.76% |
| EPS | 0.06 | 0.08 | 0.07 | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 | 0.00 | -0.02 | -0.02 | 0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.06 | 0.07 | 0.06 | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 | 0.00 | -0.02 | -0.02 | 0.01 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 4.46B | 4.23B | 4.56B | 4.34B | 4.14B | 4.33B | 4.33B | 4.00B | 4.00B | 4.00B | 4.00B | 4.00B | 3.05B | 1.92B |
| Weighted Avg Shares Out (Dil) | 4.45B | 4.41B | 4.56B | 4.39B | 4.14B | 4.36B | 4.34B | 4.00B | 4.00B | 4.00B | 4.00B | 4.00B | 3.34B | 1.92B |
Source: https://incomestatements.info
Category: Stock Reports